RESUMO
INTRODUCTION: Corpus-restricted atrophic gastritis is a chronic inflammatory disorder leading to possible development of type 1 neuroendocrine tumors (T1gNET), intraepithelial neoplasia (IEN), and gastric cancer (GC). We aimed to assess occurrence and predictors of gastric neoplastic lesions in patients with corpus-restricted atrophic gastritis at long-term follow-up. METHODS: A prospective single-center cohort of patients with corpus-restricted atrophic gastritis adhering to endoscopic-histological surveillance was considered. Follow-up gastroscopies were scheduled according to the management of epithelial precancerous conditions and lesions of the stomach guidelines. In case of new/worsening of known symptoms, gastroscopy was anticipated. Cox regression analyses and Kaplan-Meier survival curves were obtained. RESULTS: Two hundred seventy-five patients with corpus-restricted atrophic gastritis (72.0% female, median age 61 [23-84] years) were included. At a median follow-up of 5 (1-17) years, the annual incidence rate person-year was 0.5%, 0.6%, 2.8%, and 3.9% for GC/high-grade IEN, low-grade IEN, T1gNET, and all gastric neoplastic lesions, respectively. All patients showed at baseline operative link for gastritis assessment (OLGA)-2, except 2 low-grade (LG) IEN patients and 1 T1gNET patient with OLGA-1. Age older than 60 years (hazard ratio [HR] 4.7), intestinal metaplasia without pseudopyloric metaplasia (HR 4.3), and pernicious anemia (HR 4.3) were associated with higher risk for GC/HG-IEN or LG-IEN development and shorter mean survival time for progression (13.4, 13.2, and 11.1, respectively, vs 14.7 years, P = 0.01). Pernicious anemia was an independent risk factor for T1gNET (HR 2.2) and associated with a shorter mean survival time for progression (11.7 vs 13.6 years, P = 0.04) as well as severe corpus atrophy (12.8 vs 13.6 years, P = 0.03). DISCUSSION: Patients with corpus-restricted atrophic gastritis are at increased risk for GC and T1gNET despite low-risk OLGA scores, and those aged older than 60 years with corpus intestinal metaplasia or pernicious anemia seem to display a high-risk scenario.
Assuntos
Anemia Perniciosa , Gastrite Atrófica , Gastrite , Infecções por Helicobacter , Lesões Pré-Cancerosas , Neoplasias Gástricas , Humanos , Feminino , Idoso , Pessoa de Meia-Idade , Masculino , Gastrite Atrófica/complicações , Gastrite Atrófica/epidemiologia , Gastrite Atrófica/patologia , Incidência , Estudos de Coortes , Anemia Perniciosa/epidemiologia , Anemia Perniciosa/complicações , Anemia Perniciosa/patologia , Estudos Prospectivos , Gastrite/complicações , Fatores de Risco , Neoplasias Gástricas/patologia , Lesões Pré-Cancerosas/epidemiologia , Lesões Pré-Cancerosas/patologia , Metaplasia/patologia , Infecções por Helicobacter/complicações , Mucosa Gástrica/patologiaAssuntos
Anemia Megaloblástica/diagnóstico , Eritrócitos/patologia , Anemia Megaloblástica/tratamento farmacológico , Anemia Megaloblástica/patologia , Anemia Perniciosa/diagnóstico , Anemia Perniciosa/tratamento farmacológico , Anemia Perniciosa/patologia , Índices de Eritrócitos , Eritrócitos/citologia , Eritrócitos/efeitos dos fármacos , Hematínicos/uso terapêutico , Humanos , Hidroxocobalamina/uso terapêutico , Masculino , Pessoa de Meia-IdadeRESUMO
CONTEXT.: Autoimmune gastritis (AG) is a corpus-restricted chronic atrophic gastritis associated with intrinsic factor deficiency, either with or without pernicious anemia. Autoimmune gastritis is a microscopic disease because patients present with no or vague symptoms, and clinicians rarely find endoscopic changes. Autoimmune gastritis only becomes a clinical disease when pathologists diagnose it in gastric biopsies performed for a variety of clinical indications. Unfamiliarity with this disease can result in misdiagnosis of patients, and thus inadequate patient management. OBJECTIVE.: To review the pathogenesis, clinical features, diagnostic criteria, differential diagnoses, sequelae, and surveillance recommendations for AG. DATA SOURCES.: The sources of the study include a review of the pertinent literature for AG. CONCLUSIONS.: Autoimmune gastritis is an important disease characterized by a loss of oxyntic mucosa and presence of metaplastic epithelium and enterochromaffin-like cell hyperplasia. Awareness and proper diagnosis are critical to prevent mismanagement of patients.
Assuntos
Anemia Perniciosa/congênito , Doenças Autoimunes/diagnóstico , Gastrite Atrófica/diagnóstico , Hiperplasia/diagnóstico , Fator Intrínseco/deficiência , Metaplasia/diagnóstico , Anemia Perniciosa/diagnóstico , Anemia Perniciosa/patologia , Doenças Autoimunes/patologia , Biópsia , Doença Crônica , Diagnóstico Diferencial , Erros de Diagnóstico , Epitélio/patologia , Gastrite Atrófica/patologia , Humanos , Hiperplasia/patologia , Metaplasia/patologia , Estômago/patologiaRESUMO
Pernicious anemia (PA), the commonest cause of cobalamin deficiency (CD) in the world, is an autoimmune disease of multifactorial origin and is characterized by chronic atrophic gastritis (CAG) and defective absorption of cobalamin from the terminal ileum due to interference by the intrinsic factor (IF) antibodies. PA-related CD is a lengthy process, which if untreated, can lead to irreversible hematological and neurological sequelae. Although safe and effective therapy is available and the management of PA is straightforward, the diagnosis of PA can be extremely difficult to obtain due to myriad and diverse clinical presentations, frequently coexisting diseases, and limitations of currently available diagnostic tests. Diagnostic dilemmas may occur when PA patients present with normal or spuriously high serum cobalamin levels, dysplastic features of ring sideroblasts in the bone marrow (BM), hemolysis, and concomitant diseases such as iron deficiency or thalassemia. Herein, the author discusses an overview of diagnostic difficulties, with regards to morphological mimics, coexisting diseases, limitations of currently available tests, and how to diagnose PA in the era of imperfect laboratory tests.
Assuntos
Anemia Perniciosa/diagnóstico , Anemia Perniciosa/sangue , Anemia Perniciosa/complicações , Anemia Perniciosa/patologia , Autoanticorpos/sangue , Biomarcadores/sangue , Testes Hematológicos , HumanosAssuntos
Anemia Perniciosa/patologia , Carcinoma de Células em Anel de Sinete/patologia , Linite Plástica/patologia , Neoplasias Gástricas/patologia , Idoso de 80 Anos ou mais , Anemia Perniciosa/complicações , Anemia Perniciosa/cirurgia , Carcinoma de Células em Anel de Sinete/complicações , Carcinoma de Células em Anel de Sinete/cirurgia , Feminino , Humanos , Linite Plástica/complicações , Linite Plástica/cirurgia , Prognóstico , Neoplasias Gástricas/complicações , Neoplasias Gástricas/cirurgia , Tomografia Computadorizada por Raios XAssuntos
Anemia Perniciosa/diagnóstico , Anemia Perniciosa/patologia , Aberrações Cromossômicas , Anemia Perniciosa/etiologia , Anemia Perniciosa/fisiopatologia , Células da Medula Óssea/patologia , Deleção Cromossômica , Cromossomos Humanos Par 3/genética , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Síndromes Mielodisplásicas/diagnóstico , Recidiva , Indução de Remissão , Índice de Gravidade de Doença , Síncope/etiologia , Vitamina B 12/uso terapêutico , Deficiência de Vitamina B 12/tratamento farmacológico , Deficiência de Vitamina B 12/fisiopatologiaRESUMO
AIM: To investigate the presence of IgG4+ plasma cells in gastric mucosal biopsy samples from patients with atrophic gastritis (AG) and a history of pernicious anaemia (PA) (AG+PA+). METHODS: Gastric mucosal biopsy specimens from 46 patients with AG+PA+ were investigated. As controls, we evaluated specimens from patients with AG but no history of PA (AG+ PA-) (n=25), normal histology (n=25), mild chronic inactive gastritis (MCIG) (n=25) or Helicobacter pylori gastritis (HP) (n=25). IgG4+ plasma cells were detected by two immunohistochemical methods: (1) using a monoclonal antibody, the average of the three most cellular high-power fields was counted in areas with the highest density of IgG4+ plasma cells; (2) using a dual-chromagen stain for both IgG4 and CD138 (plasma cell marker), the number of IgG4+ cells per 200 CD138+ plasma cells was counted. The latter was used to ensure that the number of IgG4+ cells was not simply related to the degree of inflammation (density of plasma cells). RESULTS: Identical results were obtained with the two staining methods. Increased numbers of IgG4+ plasma cells were present in 37% of patients with AG+PA+, but in none with AG+PA-, MCIG, HP or normal gastric biopsy results (100% specific, p=0.0001). CONCLUSION: IgG4+ plasma cells may play a role in the pathogenesis of PA and may be a useful marker for its diagnosis.
Assuntos
Anemia Perniciosa/imunologia , Mucosa Gástrica/imunologia , Imunoglobulina G/análise , Plasmócitos/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Anemia Perniciosa/etiologia , Anemia Perniciosa/patologia , Biópsia , Estudos de Casos e Controles , Feminino , Mucosa Gástrica/patologia , Gastrite/imunologia , Gastrite/microbiologia , Gastrite/patologia , Gastrite Atrófica/complicações , Gastrite Atrófica/imunologia , Gastrite Atrófica/patologia , Infecções por Helicobacter/complicações , Helicobacter pylori , Humanos , Masculino , Pessoa de Meia-Idade , Sindecana-1/análiseRESUMO
INTRODUCTION: H. pylori gastritis and autoimmune gastritis are the two main types of chronic atrophic gastritis. Parietal cell antibody (PCA) and intrinsic factor antibody (IFA) are characteristic of autoimmune gastritis, of which IFA is more specific. Patients who are IFA negative are considered under the category of chronic atrophic gastritis. AIM: To differentiate IFA positive from IFA negative chronic atrophic gastritis. METHODS: Fifty consecutive patients of biopsy proven chronic atrophic gastritis were included in this study. All patients underwent haematological and biochemical tests including serum LDH, vitamin B12 and fasting serum gastrin levels. PCA and IFA antibodies were tested in all patients. Multiple gastric biopsies from body and antrum of the stomach were taken and evaluated for presence of intestinal metaplasia, endocrine cell hyperplasia, carcinoid and H. pylori infection. Patients were grouped as group A (IFA positive) and group B (IFA negative). The mean laboratory values and histological parameters were compared between the two groups using appropriate statistical methods. RESULTS: Eighteen patients were in group A (mean age 55.5 +/- 13 years, male: female = 16:2) and thirty-two in group B (mean age 49.7 +/- 13 years, male: female = 25:7). There was no statistically significant difference between median values of haemoglobin, MCV, LDH, Vitamin B12 and serum gastrin in both the groups. None of the histological parameters showed any significant difference. CONCLUSION: There was no statistically significant difference in haematological, biochemical and histological parameters in IFA positive and negative gastritis. These may be the spectrum of the same disease, where H. pylori may be responsible for initiating the process.
Assuntos
Anemia Perniciosa , Gastrite Atrófica , Fator Intrínseco/imunologia , Adulto , Idoso , Anemia Perniciosa/classificação , Anemia Perniciosa/imunologia , Anemia Perniciosa/patologia , Autoanticorpos/imunologia , Biópsia , Diagnóstico Diferencial , Endoscopia do Sistema Digestório , Feminino , Gastrite Atrófica/classificação , Gastrite Atrófica/imunologia , Gastrite Atrófica/patologia , Infecções por Helicobacter/imunologia , Infecções por Helicobacter/patologia , Helicobacter pylori , Humanos , Masculino , Pessoa de Meia-Idade , Células Parietais Gástricas/imunologiaAssuntos
Adenocarcinoma Mucinoso/diagnóstico , Adenocarcinoma Mucinoso/patologia , Anemia Perniciosa/complicações , Transformação Celular Neoplásica/patologia , Neoplasias Primárias Múltiplas/diagnóstico , Pólipos/diagnóstico , Pólipos/patologia , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/patologia , Adenocarcinoma Mucinoso/secundário , Adenocarcinoma Mucinoso/cirurgia , Anemia Perniciosa/patologia , Evolução Fatal , Feminino , Mucosa Gástrica/patologia , Hemorragia Gastrointestinal/etiologia , Gastroscopia , Humanos , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/cirurgia , Pessoa de Meia-Idade , Neoplasias Primárias Múltiplas/patologia , Neoplasias Primárias Múltiplas/cirurgia , Pólipos/cirurgia , Neoplasias Gástricas/cirurgiaRESUMO
A 27-year-old male, who had developed diabetes mellitus type 1 (DMT1) since the age of eighteen and alopecia areata universalis nine months later, attended the outpatient clinics complaining of general fatigue and shortness of breath. A Schilling test was indicative of pernicious anemia. Antigastric parietal cell (AGPA) and anti-intrinsic factor antibodies were positive, confirming diagnosis of pernicious anemia. Thyroid and Addison's disease were excluded. Gastroscopy revealed atrophic gastritis without any evidence of carcinoid tumors. The aim of this case, which, to our knowledge, is the first one to describe a correlation between diabetes mellitus Type 1 (DMT1), pernicious anaemia, and alopecia areata universalis, is to remind the clinician of the increased risk of pernicious anaemia and gastric carcinoids in DMT1 patients. Screening for AGPA followed by serum gastrin and vitamin B(12) levels constitute the most evidence-based diagnostic approach.
Assuntos
Alopecia em Áreas/complicações , Anemia Perniciosa/complicações , Diabetes Mellitus Tipo 1/complicações , Adulto , Alopecia em Áreas/imunologia , Anemia Perniciosa/imunologia , Anemia Perniciosa/patologia , Autoanticorpos/imunologia , Diabetes Mellitus Tipo 1/imunologia , Mucosa Gástrica/imunologia , Mucosa Gástrica/patologia , Humanos , Fator Intrínseco/imunologia , Masculino , Células Parietais Gástricas/imunologia , Células Parietais Gástricas/patologiaRESUMO
BACKGROUND: Mitochondrial dysfunction is one of the most characteristic properties of the cancer cell. However, it is not known whether oxidative energy metabolism has already become altered in conditions of atrophic gastritis, a precancerous state of gastric disease. The purpose of our study was to comparatively characterize oxidative phosphorylation (OXPHOS) in the atrophic and nonatrophic gastric corpus mucosa. METHODS: Mucosal biopsies were taken from 12 patients with corpus dominant atrophic gastritis and from 12 patients with nonatrophic mucosa (controls). One part of the tissue samples was permeabilized with saponin for analysis of the function of the respiratory chain using high-resolution respirometry, and another part was used for histopathological examination. The serum level of pepsinogen I (S-PGI) was determined with a specific enzyme immunoassay (EIA). RESULTS: Compared to the control group, the maximal capacity of OXPHOS in the atrophy group was almost twofold lower, the respiratory chain complex I-dependent respiration, normalized to complex II-dependent respiration, was reduced, and respiratory control by ADP in the presence of succinate was increased in the atrophic corpus mucosa. In the whole cohort of the patients studied, serum S-PGI level correlated positively with complex I-dependent respiration or complex I-dependent to complex II-dependent respiration ratio. CONCLUSIONS: Corpus dominant atrophic gastritis is characterized by decreased respiratory capacity and relative deficiency of the respiratory complex I of mitochondria in the mucosa, the latter defect probably limiting mitochondrial ATP production and energetic support of the secretory function of the zymogenic mucosal cells.
Assuntos
Complexo I de Transporte de Elétrons/metabolismo , Mucosa Gástrica/metabolismo , Gastrite Atrófica/metabolismo , Mitocôndrias/metabolismo , Fosforilação Oxidativa , Consumo de Oxigênio/fisiologia , Idoso , Anemia Perniciosa/complicações , Anemia Perniciosa/metabolismo , Anemia Perniciosa/patologia , Estudos de Casos e Controles , Respiração Celular/fisiologia , Estudos de Coortes , Feminino , Mucosa Gástrica/patologia , Gastrite Atrófica/etiologia , Gastrite Atrófica/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Pepsinogênio A/sangueRESUMO
CONTEXT: Autoimmune gastritis and pernicious anemia are common autoimmune disorders, being present in up to 2% of the general population. In patients with type 1 diabetes or autoimmune thyroid disease, the prevalence is 3- to 5-fold increased. This review addresses the epidemiology, pathogenesis, diagnosis, clinical consequences, and management of autoimmune gastritis in type 1 diabetic patients. SYNTHESIS: Autoimmune gastritis is characterized by: 1) atrophy of the corpus and fundus; 2) autoantibodies to the parietal cell and to intrinsic factor; 3) achlorhydria; 4) iron deficiency anemia; 5) hypergastrinemia; 6) pernicious anemia may result from vitamin B12 deficiency; and 7) in up to 10% of patients, autoimmune gastritis may predispose to gastric carcinoid tumors or adenocarcinomas. This provides a strong rationale for screening, early diagnosis, and treatment. The management of patients with autoimmune gastritis implies yearly determination of gastrin, iron, vitamin B12 levels, and a complete blood count. Iron or vitamin B12 should be supplemented in patients with iron deficiency or pernicious anemia. Whether regular gastroscopic surveillance, including biopsies, is needed in patients with autoimmune gastritis/pernicious anemia is controversial. The gastric carcinoids that occur in these patients generally do not pose a great threat to life, whereas the danger of developing carcinoma is controversial. Nevertheless, awaiting a consensus statement, we suggest performing gastroscopy and biopsy at least once in patients with autoantibodies to the parietal cell, iron-, or vitamin B12-deficiency anemia, or high gastrin levels. CONCLUSION: The high prevalence of autoimmune gastritis in type 1 diabetic patients and its possible adverse impact on the health of the patient provide a strong rationale for screening, early diagnosis, periodic surveillance by gastroscopy, and treatment.
Assuntos
Diabetes Mellitus Tipo 1/complicações , Gastrite Atrófica/complicações , Anemia Perniciosa/complicações , Anemia Perniciosa/imunologia , Anemia Perniciosa/patologia , Anemia Perniciosa/terapia , Autoanticorpos/sangue , Diabetes Mellitus Tipo 1/imunologia , Diabetes Mellitus Tipo 1/patologia , Diabetes Mellitus Tipo 1/terapia , Gastrite Atrófica/imunologia , Gastrite Atrófica/patologia , Gastrite Atrófica/terapia , HumanosRESUMO
INTRODUCTION: In pernicious anemia besides the presence of megaloblasts in the bone marrow, changes in myeloid series were seen; being the most evident among the metamyelocyte. The aim of this study was to perform the quantification of metamyelocyte of the bone marrow in pernicious anemia. MATERIAL AND METHODS: Between 2000-2006 in the Clinic of Hematology-Nis, 68 patients with pernicious anemia were examined and 30 with dyspeptic syndrome (control group). The group of patients with pernicious anemia in relation to pathohistologic changes of gastric mucosa was divided into three sub-groups. Morphometrical analysis of metamyelocyte of the bone marrow was carried out by the application of the double netlike system (B100). The following parameters were used: relative surface, contour length, absolute surface of nucleus and cytoplasm, absolute contour nucleus and cytoplasm density, shaped nucleus and cytoplasmic factor and nuclear-cytoplasmatic ratio of metamyelocytes. RESULTS: Relative surface, contour length, absolute surface and contour density of nucleus and cytoplasm of metamyelocytes increased simultaneously with the degree of atrophic gastritis. Shaped nucleus and cytoplasmic factor and nuclear-cytoplasmatic ratio of metamyelocytes decreased in all examined groups in relation to the control group. CONCLUSION: Not only are bone marrow erythroid elements scoped with megaloblastic changes but the changes on the level of leukocyte cells as well. The result of this is the phenomena of giant metamyelocytes.
Assuntos
Anemia Perniciosa/patologia , Medula Óssea/patologia , Células Precursoras de Granulócitos/patologia , Anemia Perniciosa/complicações , Dispepsia/complicações , Gastrite Atrófica/complicações , HumanosRESUMO
Here, we report a rare coincidence of heterozygous hemoglobinopathy (Hb) Stanleyville II and severe pernicious anemia due to autoimmune gastritis. Hb Stanleyville II is characterized by a single base exchange (AAC-->AAA) resulting in a substitution Asn --> Lys at position 78 of hemoglobin alpha2-chain. Under normal conditions this hemoglobinopathy does not cause any symptoms even if present as homozygous variant. However, in our case diagnosis of pernicious anemia was hampered by the absence of typical erythrocytic macrocytosis and hyperchromasia. In addition, interpretation of bone marrow smears was difficult as characteristic findings for pernicious anemia were little pronounced. All known reasons for the absence of typical cytomorphologic signs in pernicious anemia as underlying iron deficiency and thalassemia could be excluded.
Assuntos
Anemia Perniciosa/genética , Anemia Perniciosa/patologia , Hemoglobinopatias/genética , Hemoglobinopatias/patologia , Hemoglobinas Anormais/genética , Mutação de Sentido Incorreto , Adulto , Substituição de Aminoácidos , Anemia Perniciosa/complicações , Medula Óssea/patologia , Diagnóstico Diferencial , Hemoglobinopatias/complicações , Humanos , MasculinoRESUMO
Pernicious anemia is a megaloblastic anemia caused by vitamin B12 deficiency, and is the end-stage of autoimmune gastritis that typically affects persons older than 60 years. It is the most common cause of vitamin B12 deficiency. Pernicious anemia can also be diagnosed concurrently with other autoimmune diseases. We report the occurrence of megaloblastic anemia in a 22-year-old woman with chronic autoimmune thyroiditis for 10.5 years. Recently, she presented with microcytic anemia, and iron deficiency anemia was diagnosed initially. After administration of ferrous sulfate, macrocytic anemia was revealed and vitamin B12 deficiency was detected. Pernicious anemia was highly suspected because of the endoscopic finding of atrophic gastritis, and high titer of antigastric parietal cell antibody, as well as elevated serum gastrin level. After intramuscular injections of hydroxycobalamine 100 microg daily for 10 days, and monthly later, her blood counts returned to normal.
Assuntos
Anemia Ferropriva/tratamento farmacológico , Anemia Perniciosa/tratamento farmacológico , Compostos Ferrosos/administração & dosagem , Doença de Hashimoto/tratamento farmacológico , Hematínicos/administração & dosagem , Hidroxocobalamina/administração & dosagem , Deficiência de Vitamina B 12/tratamento farmacológico , Adulto , Anemia Ferropriva/sangue , Anemia Ferropriva/etiologia , Anemia Ferropriva/patologia , Anemia Perniciosa/sangue , Anemia Perniciosa/etiologia , Anemia Perniciosa/patologia , Feminino , Gastrite Atrófica/sangue , Gastrite Atrófica/tratamento farmacológico , Gastrite Atrófica/etiologia , Gastrite Atrófica/patologia , Doença de Hashimoto/sangue , Doença de Hashimoto/complicações , Doença de Hashimoto/patologia , Humanos , Deficiência de Vitamina B 12/sangue , Deficiência de Vitamina B 12/complicações , Deficiência de Vitamina B 12/patologiaRESUMO
CONTEXT: Pernicious anemia (PA) is an autoimmune organ disease much more common in type 1 diabetic patients (DM1) than in nondiabetic subjects, but it is clinically silent until its end stage. OBJECTIVE: This study aimed to determine biochemical markers of latent PA in a population of DM1 patients attending the endocrinology outpatient clinic of a university hospital. STUDY SUBJECTS: The population studied consisted of 186 unselected patients (32.4 +/- 8.7 yr) and 118 healthy controls (30.9 +/- 9.4 yr). MEASUREMENTS AND INTERVENTIONS: Plasma gastrin and pepsinogen I were determined in patients and controls, whereas hemoglobin A1c, serum cobalamin, hemoglobin, and organ-specific antibodies were determined only in patients. Latent PA was defined as serum pepsinogen I less than 30 microg/liter. In patients with low pepsinogen I concentrations and hypergastrinemia, esophagogastroduodenoscopy (EGD) was performed. RESULTS: DM1 patients showed significantly lower pepsinogen I concentrations (P < 0.001) and higher gastrinemia than controls. Latent PA was present in 12.4% of patients vs. 0.9% of controls. Among patients, more women than men showed low plasma pepsinogen I concentrations (P = 0.002) and thyroperoxidase antibody positivity (P < 0.001). Only the highest parietal cell antibody titers (> or =1:640) identified patients with significantly higher levels of plasma gastrin (P < 0.001) and lower levels of pepsinogen I (P < 0.001). The histopathological EGD findings confirmed different degrees of gastric body mucosa atrophy in all cases. CONCLUSION: The high prevalence of latent PA found in our DM1 patients leads us to recommend its screening using serum pepsinogen I concentrations. In patients with hypergastrinemia and high parietal cell antibody titers, EGD should be considered to confirm gastric mucosa atrophy.